2026 · 2nd Quarter (Apr 1 - June 30)

BECTON DICKINSON AND COMPANY

Filed by BECTON, DICKINSON AND COMPANY.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: Not reported
Expenses: $622,000.00
Registrant: BECTON, DICKINSON AND COMPANY
Client: BECTON DICKINSON AND COMPANY
Filing UUID: 1d55521b-34e6-4587-b995-63be13078155
Termination date: Not reported

Expense method: C

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines

HCR · Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health

TAX · Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

BUD · Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act

TRD · Trade (domestic/foreign)

Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.